日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lobeglitazone improves glycaemic control as add-on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double-blind, randomised, placebo-controlled trial

在2型糖尿病患者中,洛贝格列酮作为恩格列净联合二甲双胍治疗的附加疗法可改善血糖控制:一项双盲、随机、安慰剂对照试验

Seo, Da Hea; Min, Kyung Wan; Sohn, Ho Sang; Kim, Sang Yong; Jeong, In-Kyung; Park, Cheol-Young; Yoon, Kun-Ho; Kim, So Hun; Cha, Bong-Soo

Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double-blind, multicentre, therapeutic confirmatory phase 3 clinical trial

恩格列净联合治疗二甲双胍和西格列汀控制不佳的2型糖尿病患者的疗效和安全性:一项随机、双盲、多中心、治疗验证性3期临床试验

Lee, Seung-Hwan; Han, Kyung Ah; Hong, Eun-Gyoung; Kang, Jun Goo; Chung, Choon Hee; Won, Jong Chul; Jeon, Eon Ju; Cho, Jung-Hwan; Cho, Ho Chan; Kim, Sin Gon; Kang, Eun Seok; Kim, So Hun; Kim, Hae Jin; Jeong, In-Kyung; Chun, Sung Wan; Cho, Young Min

Second Asian Consensus Report on Functional Dyspepsia (2025): Updated Recommendations

第二份亚洲功能性消化不良共识报告(2025):更新建议

Mahadeva, Sanjiv; Siah, Kewin Tien Ho; Ghoshal, Uday C; Suzuki, Hidekazu; Lee, Yeong Yeh; Chuah, Kee Huat; Chung, Vincent; Zhong, Linda; Tay, Benjamin Wei-Rong; Ang, Ban Hong; Sinnanaidu, Ram Prasad; Bai, Tao; Oshima, Tadayuki; Patcharatrakul, Tanisa; Sachdeva, Sanjeev; Tseng, Ping-Huei; Liu, Jinsong; Xiao, Yinglian; Vilaichone, Ratha-Korn; Lee, Joon Seong; Oh, Jung-Hwan; Syam, Ari Fahrial; Lu, Ching Liang; Ang, Tiing Leong; Sung, In-Kyung; Hou, Xiao-Hua; Sugano, Kentaro; Wu, Justin; Miwa, Hiroto

2025 Focused Update of the Seoul Consensus on Gastroesophageal Reflux Disease: Evidence-based Recommendations on Acid Suppressive Therapy

2025年首尔胃食管反流病共识更新:基于循证医学的抑酸治疗建议

Huh, Cheal Wung; Chang, Jin Won; Son, Nak-Hoon; Jung, Da Hyun; Jung, Hye-Kyung; Kang, Seung Joo; Kim, Seung Young; Choi, Miyoung; Jeong, Da Mi; Kim, Hyun Jin; Park, Moo In; Sung, In-Kyung; Youn, Young Hoon; Lee, Kwang Jae

Study Design and Protocol for a Randomized Controlled Trial of Enavogliflozin to Evaluate Cardiorenal Outcomes in Type 2 Diabetes (ENVELOP)

评估依那格列净对 2 型糖尿病患者心肾结局的随机对照试验的研究设计和方案 (ENVELOP)

Kim, Nam Hoon; Lim, Soo; Jeong, In-Kyung; Rhee, Eun-Jung; Moon, Jun Sung; Ryu, Ohk-Hyun; Kwon, Hyuk-Sang; Won, Jong Chul; Kim, Sang Soo; Kim, Sang Yong; Ku, Bon Jeong; Jin, Heung Yong; Kim, Sin Gon; Cha, Bong-Soo

Journal of Lipid and Atherosclerosis in 2025: From Excellence to Eminence

《脂质与动脉粥样硬化杂志》2025年展望:从卓越走向辉煌

Curtis, Helen J; Walker, Alex J; Goldacre, Ben; Jeong, In-Kyung

Evaluation of the efficacy and safety of controlled-release phentermine/topiramate in adults with obesity in Korea: A randomized, double-blind, placebo-controlled, phase 4 trial (QUEEN's study)

评估控释芬特明/托吡酯在韩国肥胖成人中的疗效和安全性:一项随机、双盲、安慰剂对照的 4 期试验(QUEEN 研究)

Hong, Sangmo; Kim, Won Jun; Kang, Eun Seok; Jeong, In-Kyung; Kim, Chong Hwa; Lee, Ki Young; Kim, Sungrae; Oh, Seung Joon; Lee, Chang Beom

EffiCacy and safety of ANagliptin when added to iNsulin and metformin therapy in patients with uncontrolled type 2 diAbetes; randomized, placebo-controlled, double-blind, multicentre trial (CANNA study)

在未控制的 2 型糖尿病患者中,加用阿格列汀联合胰岛素和二甲双胍治疗的疗效和安全性;随机、安慰剂对照、双盲、多中心试验(CANNA 研究)

Jun, Ji Eun; Choi, Sung Hee; Moon, Min Kyong; Ko, Seung-Hyun; Kim, Hae Jin; Hur, Kyu Yeon; Rhee, Eun-Jung; Noh, Jung Hyun; Jeong, In-Kyung

Association of carotid atherosclerosis with brain tissue integrity and metabolic parameters in type 2 diabetes patients

颈动脉粥样硬化与2型糖尿病患者脑组织完整性和代谢参数的关系

Lim, Seung Hoon; Ryu, Chang-Woo; Tian, Yunan; Jun, Ji Eun; Park, Soonchan; Jeong, In-Kyung; Jahng, Geon-Ho

Discrepancies in Dapagliflozin Response in Terms of Glycemic Control and Body Weight Reduction

达格列净在血糖控制和体重减轻方面的反应差异

Jun, Ji Eun; Kim, Kyoung-Ah; Kim, Nan-Hee; Lee, Kwan-Woo; Jeong, In-Kyung